latest news releases from the newsroom
National Corn Growers Association
NCGA Names National Corn Yield Contest Winners
ST. LOUIS, Dec. 17, 2007 (PRIME NEWSWIRE) -- Innovative production techniques and improved seed varieties helped corn growers achieve top numbers in the National Corn Grower Association (NCGA) 2007 National Corn Yield Contest. Not only was the number of entries higher than ever before, but several entrants scored yields of more than double the estimated average.
D Mecatronics Inc.
D Mecatronics Shareholders Vote in Favor of Preliminary Purchase Proposal
MISSISSAUGA, Ontario, Dec. 17, 2007 (PRIME NEWSWIRE) -- D Mecatronics Inc. (Pink Sheets:DMTN) today announced that its shareholders voted at a special meeting held on Friday, December 14, 2007 in favor of the preliminary purchase proposal it recently received from Investment Company "LesKo," a Russian investment company. A quorum of shareholders was present at the meeting in person or by proxy, and the voting of the shareholders at the meeting was unanimous in favor of the preliminary proposal.
Verizon Wireless Expands Wireless Broadband Network to More of Northwest Indiana
RENSSELAER, Ind., Dec. 17, 2007 (PRIME NEWSWIRE) -- Verizon Wireless announced today that it has expanded the national rollout of its high-speed wireless network to more of northwest Indiana, including Demotte, Monon, Monticello, Rensselaer, Reynolds, Roselawn and Wolcott, and along Interstate 65 through Jasper and White counties.
Hemispherx Biopharma, Inc.
Hemispherx Biopharma Announces Investors Conference Call
PHILADELPHIA, Dec. 17, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has scheduled an Investor Conference Call and webcast to take place on Wednesday, December 19, 2007 at 4:00 p.m. EST. Dr. William Carter, Chairman and CEO, will discuss the recently announced licensing/research agreements with vaccine manufacturers for the use of the Company's experimental drug Ampligen(r) as an immune enhancer to influenza vaccines. The discussion will also include market data from PricewaterhouseCoopers which includes information on vaccine developments, Toll Like Receptors (TRL) under development, as well as the cost parameters of such development. As part of a continuation from last week's conference call, discussion will also focus on the pre-clinical comments cited by the U.S. Food and Drug Administration regarding the company's New Drug Application for the potential treatment of Chronic Fatigue Syndrome.